AstraZeneca vaccine authorized for use in Korea on Feb. 10

By Lee, Tak-Sun | translator Byun Kyung A

21.02.08 17:09:05

가나다라 0

Final Inspection Committee convened to make the decision, a first COVID-19 vaccine to be approved in South Korea

Approved for vaccinating adults aged over 65 but with warning

The COVID-19 vaccine developed by AstraZeneca was finally approved by the South Korean health authority on Feb. 10. The approval is valid for the age group over 18, including elders older than 65.

On Feb. 10, South Korea’s Ministry of Food and Drug Safety (MFDS) convened a Final Inspection Committee to make a decision on authorizing AstraZeneca’s COVID-19 vaccine, and officially announced the result.

Similar to Celltrion’s anti-COVID-19 monoclonal antibody treatment, the Final Inspection Committee gathered and agreed on a final decision for the vaccine on the same day. Expert Committee meetings were held twice prior to the final meeting and gave a positive result.

Pr

Lee, Tak-Sun(hooggasi2@dailypharm.com)

If you want to see the full article, please JOIN US (click)